Evidence map›Paper›PMID 31182758›Full record

ArticleScientific reports2019

Risk factors for neurocognitive impairment in patients with benign intracranial lesions.

Stefanie Bette, Julia M Ruhland, Benedikt Wiestler, Melanie Barz, Bernhard Meyer, Claus Zimmer, Yu-Mi Ryang, Florian Ringel, Jens Gempt

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stefanie BetteDepartment of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Julia M RuhlandDepartment of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Benedikt WiestlerDepartment of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Melanie BarzDepartment of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Bernhard MeyerDepartment of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Claus ZimmerDepartment of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Yu-Mi RyangDepartment of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Florian RingelDepartment of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Jens GemptDepartment of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. jens.gempt@tum.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was designed to assess risk factors for neurocognitive impairment in patients with benign intracranial lesions including tumors and vascular lesions. 74 patients (29 m, 51 f, mean age 54.4 years) with surgery for benign intracranial lesions were included in this prospective single-center study. Extensive neuropsychological testing was performed preoperatively, including tests for attention, memory and executive functions. Furthermore, headache and depression were assessed using the german version of the HDI (IBK) and the BDI-II. Multiple linear regression analyses of the percentile ranks (adjusted for age, sex and education) including the parameters age, Karnofsky Performance Status Scale (KPS), mood, pain and lesion size were performed to identify risk factors for cognitive impairment. Using the Mann-Whitney U test, the influence of hemisphere and type of lesion (tumor/vascular) was assessed. Posthoc Bonferroni correction was performed. Poorer neurocognitive functions were observed only in the category attention in patients with higher age (divided attention, WMS) and reduced KPS (WMS). Lesion volume, mood, pain, hemisphere or the type of the lesion (tumor, vascular) were not identified as risk factors for poorer neurocognitive functions in patients with benign intracranial lesions. Age and KPS are the main risk factors for poorer neurocognitive functions in the category attention in patients with benign intracranial lesions. Knowledge of these risk factors might be important to find appropriate therapy regimes to improve cognitive functions and quality of life.

Indexed as

AffectBrain NeoplasmsCognitionCognitive DysfunctionExecutive FunctionFemaleHumansMaleMiddle AgedNeuropsychological TestsPainRisk Factors

Identifiers

PMID31182758
PMCPMC6557851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.